No No Optune is a projected 13% survival rate from 2.5 years. In their specific case we are not aware of ANY actual survivors at 5 years. NWBO’s DCVax will be an actual rate at 5 years. One cannot compare the 2 products. I have seen Optune fail first hand. Have you?
Market Data 
Markets 
AI
